Search
Utilisation of Pharmacogenomics Testing in Clinical Research: Program
| Talk Title | Speaker | Abstract | Duration |
|---|---|---|---|
| Current application of genomics in clinical practice. Utilising pharmacogenomics to inform prescribing | Dr. Les Sheffield and Tara Smith | Learn how an individual’s genetic make-up can affect the way they respond to certain medications and may help to predict non-response or an increased risk of adverse effects. The presentation includes a case study and also looks at a current research project investigating the benefits of pharmacogenomic testing in the treatment of depression. | 20 mins |
| An Australian Trial of Genotype-Guided Pharmacotherapy For Depression: THE ALIGNED STUDY | A/Prof Kathy Wu | Pharmacogenomics is a genetic test that assesses multiple actionable variants that influence medication metabolism/response. Pharmacogenomics-guided prescription enables tailored treatment and has been shown to be beneficial in depression where current treatment is based on trial-and-error iterations. We have developed an interdisciplinary program and shown that it is feasible to integrate pharmacogenomics into routine care of mental illness. Informed by the pilot program, the ALIGNED study is a multicentre double-blind randomised controlled trial of genotype-guided versus standard psychotropic therapy in people with depression who are initiating pharmacotherapy. | 20 mins |
| Panel discussion/ Q&A | Bansi Sanghvi | 10 mins |
For Research Use Only. Not for use on diagnostic procedures.
©2023 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its subsidiaries, unless otherwise specified.